Warren Buffett Comments on Valeant Pharma (VRX)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Warren Buffett Comments on Valeant Pharma (VRX)

Valeant (VRX) 10-K Not Enough to Bring Back the Bulls or Scare The Bears - BMO Capital

May 2, 2016 9:56 AM EDT

BMO Capital analyst Alex Arfaei reiterated a Market Perform rating and lowered his price target on Valeant Pharmaceuticals (NYSE: VRX) to $44.00 (from $66.00), saying the 10K is not enough to bring back the bulls or scare the bears.

Arfaei commented, "The good news was that we didnt find any new smoking guns in the 10-K. Valeant has averted technical default on its debt, and based on our... More

Valeant's (VRX) Debt Covenants Remain a Concern After 10K Filing - Piper Jaffray

May 2, 2016 7:43 AM EDT

Piper Jaffray analyst, David Amsellem, noted that Valeant's (NYSE: VRX) 10K for 2015 contained one kernel of good news: it cured the default on its senior notes related to the late filing. Unfortunately that was "the only piece of good news". Here are the problems:

Wholesaler inventory... More